ENTITY

Stemline Therapeutics (STML US)

Health Care • United States

Stemline Therapeutics Inc. provides biopharmaceutical services. The Company offers research, discovery, and development of novel compounds that target cancer stem cells.

Refresh

Focused

No publications yet

Add Stemline Therapeutics to your Watchlist to get alerts on new publications

Add to Watchlist

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00